News | July 16, 2021
Jubilant Pharmova’s Roorkee facility placed under import alert
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
The company has already embarked upon significant expansion in Turkey
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
The company has predominantly built a portfolio into veterinary products
The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end user know it is safe to use
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
The company expects to see steady performance led by new launches and gradual normalization post the scale-up in vaccination
The agreements between the parties involve a total fee of Rs. 8 lakh plus taxes for the grant of the licenses on a non-exclusive basis to SPL
The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access
Subscribe To Our Newsletter & Stay Updated
